Société Générale Effekten GmbH Stock

Certificat

DE000SN60394

Real-time Boerse Frankfurt Warrants 12:11:18 2024-06-07 pm EDT
100.1 USD -0.01% Intraday chart for Société Générale Effekten GmbH
Current month+0.69%
1 month+0.06%
Date Price Change
24-06-07 100.1 -0.01%
24-06-06 100.1 +0.01%
24-06-05 100.1 +0.13%
24-06-04 99.94 +0.15%
24-06-03 99.79 +0.40%

Real-time Boerse Frankfurt Warrants

Last update June 07, 2024 at 12:11 pm EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SN6039
ISINDE000SN60394
Date issued 2024-01-10
Strike 105.9 $
Maturity 2025-01-10 (217 Days)
Parity 0.11 : 1
Emission price 100 $
Emission volume N/A
Settlement both
Currency USD

Technical Indicators

Highest since issue 100.8 $
Lowest since issue 99.07 $
Spread 1 $
Spread %0.10%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.5 USD
Average target price
142.7 USD
Spread / Average Target
+9.32%
Consensus